Humana Inc.

Valuation Analysis

About the Company

Humana Inc. en bref

Humana Inc. (HUM) is currently trading at 314,76 € with a market capitalization of 37,8 Md €. The trailing P/E ratio stands at 38.41x, with a forward P/E of 22.92x. The 52-week range spans from 142,34 € to 332,37 €; the current price is 5.3% below the yearly high. Year-over-year revenue growth stands at +23.5%. The net profit margin stands at 0.82%.

💰 Dividende

Humana Inc. pays an annual dividend of 3,09 € per share, representing a yield of 0.98%. The payout ratio stands at 37.78%.

📊 Avis des analystes

24 analystes évaluent Humana Inc. (HUM) au consensus : Conserver. L'objectif de cours moyen est de 263,22 €, soit un potentiel de -16.37% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 170,17 € à 384,85 €.

Humana Inc. : la thèse d'investissement en détail

Humana Inc. (HUM) operates in the Healthcare — specifically Healthcare Plans — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 23.5% pace year-over-year, suggesting the business model continues to find new customers and pricing power.

Le scénario baissier

With a net margin of just 0.82%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

À surveiller

• The forward P/E of 22.92x is meaningfully below the trailing 38.41x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 90.7% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (5.79%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Humana Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.